Cell Growth & Differentiation, Vol 8, Issue 12 1317-1328, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2

H Tsushima, Y Urata, Y Miyazaki, K Fuchigami, K Kuriyama, T Kondo and M Tomonaga
Department of Hematology, Nagasaki University School of Medicine, Japan.

Erythropoietin (Epo) is a cytokine known to stimulate proliferation and differentiation of erythroid cells. However, recent gene disruption experiments demonstrated that Epo receptor signaling is not an obligatory step in erythroid differentiation. Here, we describe the role of Epo in proliferation, terminal differentiation, and apoptosis in a novel human Epo-dependent cell line, AS-E2. Upon withdrawal of Epo, the cells ceased to proliferate and underwent apoptotic death. Accompanying this cell death, an increase in the number of hemoglobin-positive cells of approximately 2-fold was observed. This was associated with immediate up-regulation of the GATA-1:GATA-2 ratio and down-regulation of Bcl-xL. Treatment with Epo or 12-O-tetradecanoyl-phorbol-13-acetate (TPA) up-regulated expression of GATA-2 and Bcl-xL, and these elevations were inhibited by inhibitors of protein kinase C (PKC), H7 and H8. HA1004, a structural analogue of H7 but a poor inhibitor of PKC, had no inhibitory effect. Therefore, in AS-E2 cells, it is likely that Epo plays a role in (a) proliferation, (b) inhibition of differentiation, and (c) survival, by maintaining GATA-2 and Bcl-xL expression through activation of PKC.

This article has been cited by other articles:

				K. Hafid-Medheb, Y. Augery-Bourget, M.-N. Minatchy, N. Hanania, and J. Robert-Lezenes Bcl-XL is required for heme synthesis during the chemical induction of erythroid differentiation of murine erythroleukemia cells independently of its antiapoptotic function Blood, April 1, 2003; 101(7): 2575 - 2583. [Abstract] [Full Text] [PDF]

				D. R. Mercatante, J. L. Mohler, and R. Kole Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents J. Biol. Chem., December 13, 2002; 277(51): 49374 - 49382. [Abstract] [Full Text] [PDF]

				D. Imanishi, K. Yamamoto, H. Tsushima, Y. Miyazaki, K. Kuriyama, M. Tomonaga, and T. Matsuyama Identification of a Novel Cytokine Response Element in the Human IFN Regulatory Factor-1 Gene Promoter J. Immunol., October 1, 2000; 165(7): 3907 - 3916. [Abstract] [Full Text] [PDF]

				M. Haslauer, K. Baltensperger, and H. Porzig Erythropoietin- and Stem Cell Factor-Induced DNA Synthesis in Normal Human Erythroid Progenitor Cells Requires Activation of Protein Kinase Calpha and Is Strongly Inhibited by Thrombin Blood, July 1, 1999; 94(1): 114 - 126. [Abstract] [Full Text] [PDF]

				M. von Lindern, M. P.-v. Amelsvoort, T. van Dijk, E. Deiner, E. van den Akker, S. van Emst-de Vries, P. Willems, H. Beug, and B. Lowenberg Protein Kinase C alpha Controls Erythropoietin Receptor Signaling J. Biol. Chem., October 27, 2000; 275(44): 34719 - 34727. [Abstract] [Full Text] [PDF]